Worlds Collide: Safety and Danger

Psychedelic-assisted therapies present complex safety and ethical challenges as these substances transition into mainstream clinical practice. While often praised for their transformative therapeutic potential, their administration involves significant risks, including rare physiological complications, severe dissociative states, and potential abuse within the therapeutic relationship. The panel underscores the necessity of moving beyond overly clinical, pathologizing approaches to better account for these dangers. Concerns regarding patient safety in both clinical and underground contexts are addressed, particularly the need for robust guidelines, thorough patient screening, and specialized training to mitigate risks like re-traumatization. The speakers advocate for a more nuanced understanding of safety that includes psychological support and transparent communication about potential adverse effects. By fostering dialogue and prioritizing participant welfare, the field aims to navigate the complexities safely as psychedelic medicine scales in legitimate environments.